Breaking News
September 22, 2018 - Concern over fussy eating prompts parents to use non-responsive feeding practices
September 22, 2018 - Novel mathematical approach uncovers existence of unsuspected biological cycles
September 22, 2018 - Cancer Research UK invests £14 million to transform London into cancer biotherapeutics hub
September 22, 2018 - Scientists predict how well the body will fight lung cancer by analyzing immune cell shapes
September 22, 2018 - New outbreak of rare eye disease identified in contact lens wearers
September 22, 2018 - Iterum Initiates SURE 2 and SURE 3 Phase 3 Clinical Trials of IV and Oral Sulopenem in Complicated Urinary Tract and Complicated Intra-abdominal Infections
September 22, 2018 - Research finds divide in dental health accessibility between city and regional areas
September 22, 2018 - Premature babies show better brain development when fed breast milk, finds study
September 22, 2018 - Novel system uses AI to detect abnormalities in fetal hearts
September 22, 2018 - UNC scientists reveal new approach to prevent obesity and diabetes
September 22, 2018 - CWRU receives NIH grant to learn how non-coding genes contribute to spread of colorectal cancer
September 22, 2018 - Scientists better understand influenza virus and how it spreads
September 22, 2018 - Scientists to focus on length of time when a person is alive and healthy
September 22, 2018 - Study shows positive financial impacts of Medicaid expansion for low-income Michigan residents
September 22, 2018 - Innovative approach for developing vaccine against most prevalent human malaria parasite
September 22, 2018 - Inhibiting NF-kB improves heart function in a mouse model of Duchenne muscular dystrophy
September 22, 2018 - Introducing new EMR system may affect several aspects of clinic workflow
September 22, 2018 - Study finds why some human genes are more popular with biomedical researchers
September 22, 2018 - Finding epigenetic signature appears to predict inflammation risk in serious type of IBD
September 22, 2018 - Researchers develop light-based technique to measure very weak magnetic fields
September 22, 2018 - UAB researchers study dysfunction of the immune system associated with NSAID carprofen
September 22, 2018 - QIAGEN and DiaSorin launch automated, CE-marked workflow for high-throughput TB screening
September 22, 2018 - Researchers identify new genetic disorder in a human patient
September 22, 2018 - Cardiac MR With Contrast Feasible in Developing World
September 22, 2018 - Daily low-dose aspirin doesn’t reduce heart-attack risk in healthy people
September 21, 2018 - Children with asthma found to be disadvantaged in education and future occupation
September 21, 2018 - Interaction of chemical slurry and ancient shale in fracking wastewater causes radioactivity
September 21, 2018 - Scientists use mice to study transmission of Lyme disease bacteria by infected ticks
September 21, 2018 - Researchers find that sample size is key factor determining accuracy of study results
September 21, 2018 - Study shows how the drive to eat overpowers the brain’s signal to stop
September 21, 2018 - 30 Million Americans Now Have Diabetes
September 21, 2018 - Thousands of breast cancer gene variants engineered and analyzed
September 21, 2018 - The current fellowship interview process is cumbersome — Stanford researchers have a better idea
September 21, 2018 - Progenitor cells for human bone and cartilage have been identified
September 21, 2018 - Study reveals new therapeutic target for pediatric tumor-associated intractable epilepsy
September 21, 2018 - SLU’s College professor receives NIH grant to develop I-TEST project
September 21, 2018 - DermTech completes enrollment in clinical study to assess DNA damage and reversal
September 21, 2018 - Grieving patients treated with talk therapy have lower risk of suicide and psychiatric illness
September 21, 2018 - NIH and FDA call for eliminating involvement of RAC in human gene therapy experiments
September 21, 2018 - New system uses algorithm to convert 2D videos into 3D printed ‘motion sculptures’
September 21, 2018 - Sea squirt model reveals key molecules in dopaminergic neuron differentiation
September 21, 2018 - Effective management of neonatal abstinence syndrome requires coordinated ‘cascade of care’
September 21, 2018 - Refugees seek care for wounds of war
September 21, 2018 - Under the sea, in an octopus’ garden on ecstacy
September 21, 2018 - Eating foods with low nutritional quality ratings linked to cancer risk in large European cohort
September 21, 2018 - Giving kids honest information about water consumption may help them make healthy choices
September 21, 2018 - Horwitz Prize Awarded for Work on Hormones
September 21, 2018 - CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients
September 21, 2018 - Scientists discover new molecules that work together to remove unwanted DNA
September 21, 2018 - Dr. Fenella France to deliver 2019 Plenary Lecture
September 21, 2018 - New research finds that MHC-II molecules have more influence on tumors than MHC-I
September 21, 2018 - Researchers study effects of cardiac cycle in simple learning task
September 21, 2018 - FDA takes new steps to address opioid crisis by approving Opioid Analgesic Risk Evaluation and Mitigation Strategy
September 21, 2018 - Positive Barhemsys Phase 3 Treatment Data Published in Anesthesia & Analgesia
September 21, 2018 - Celiac Disease Screening: MedlinePlus Lab Test Information
September 21, 2018 - Autism linked to egg cells’ difficulty creating large proteins
September 21, 2018 - Tweaking nuclear pores could provide new avenue to battle against cancer
September 21, 2018 - Experts warn health care providers to slow down in allowing smart pill in patient care settings
September 21, 2018 - MoreGrasp reports breakthrough development of grasp neuroprosthetics activated by thought control
September 21, 2018 - Study reveals new way to target HER2-negative metastatic breast cancer
September 21, 2018 - CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL
September 21, 2018 - Study offers solid link between visceral organs and brain’s reward, motivation system
September 21, 2018 - First U.S. patient treated with innovative gene therapy at Bascom Palmer Eye Institute
September 21, 2018 - New study shows how Ethiopia has managed to achieve extraordinary progress
September 21, 2018 - Choroidal Detachment – The American Society of Retina Specialists
September 21, 2018 - New clinical trial evaluates aesthetic results of conservative surgery in breast cancer
September 21, 2018 - Discovery of a key protein involved in the development of autism
September 21, 2018 - Air pollution appears to be linked to increased risk of developing dementia
September 21, 2018 - Henry Ford Health System receives $600k grant to study genetic makeup of gliomas
September 21, 2018 - Arthritis common in individuals with varying degrees of depression, finds study
September 21, 2018 - Scientist intends to fight pathogenic bacteria with viruses
September 21, 2018 - New research suggests link between PFAS chemicals and hyperthyroidism in pet cats
September 21, 2018 - Multi-year study data shows impact of new soft contact lens to slow myopia progression in children
September 21, 2018 - Neuroscientists identify circuit for brain’s statistical inference about motion
September 21, 2018 - MILabs’ VECTor6 system wins Commercial Innovation Award at WMIC 2018
September 21, 2018 - Scientists find wild African monkeys infected with bacterium that causes syphilis, yaws in humans
September 21, 2018 - 2006 to 2015 Saw Increase in Severe Maternal Morbidity
September 21, 2018 - Similar changes in the brains of patients with ADHD and emotional instability
September 21, 2018 - Cobalt mining in DR Congo takes a high toll on both creuseurs and environment
September 21, 2018 - Eating fatty fish during pregnancy may boost unborn child’s brain development
Lower Dose of Prostate Cancer Drug with Food

Lower Dose of Prostate Cancer Drug with Food

image_pdfDownload PDFimage_print

April
23, 2018, by NCI Staff

Findings from a new clinical trial suggest that a much smaller dose of the cancer drug abiraterone (Zytiga) taken with a low-fat breakfast may be as effective as the full dose taken on an empty stomach, as directed on the drug’s label.

It’s unclear from the study whether, over the long term, patients taking the lower dose will do as well as those taking the full dose in terms of how long they live overall. But as concern continues to mount about the increasing cost of cancer drugs, the trial’s findings raise the prospect that something as simple as taking some cancer drugs with food may help to address the issue.

In the small clinical trial, Mark Ratain, M.D., of the University of Chicago, and his colleagues tested whether they could exploit what is known as the food effect to reduce the needed dose of abiraterone, a standard treatment for men with metastatic prostate cancer.

Men who took one-quarter of the normally prescribed dose of abiraterone with food had similar reductions in prostate-specific antigen (PSA) levels—a biomarker used to track prostate cancer progression—as men who took the full dose on an empty stomach, they reported March 28 in the Journal of Clinical Oncology.

Although it is effective in slowing the progression of metastatic cancer, abiraterone is one of the most expensive drugs on the market, explained William Figg, Sr., Pharm.D., of NCI’s Center for Cancer Research, an investigator on the study. “We’re trying to find ways to offset the exorbitant cost of these cancer drugs, and this is one potential approach,” Dr. Figg said.

Full Stomach, Smaller Dose

Many drugs that are given by mouth have a food effect: when a drug is taken with a meal instead of on an empty stomach, the body can absorb more of it. This is because the fat molecules found in food carry the drug efficiently through the stomach and intestines, Dr. Ratain explained. So less of the drug is needed when taken with food to produce the same concentration in the bloodstream.

Drugs with a strong food effect are often tested in a way that intentionally diminishes this effect, he continued. This is done to reduce the potential variability in dose between participants that could arise due to what types of and how much food different people eat.

And so, although the food effect of abiraterone has long been recognized, the large clinical trials that led to the drug’s approval required that participants take it on an empty stomach. As a result, the drug’s label directs patients to take it without food.

The new trial tested the opposite approach. The researchers randomly assigned 72 men with metastatic prostate cancer that had progressed on other standard therapies to take either the label-directed dose of abiraterone without food or one-quarter of that dose with a low-fat breakfast of the patients’ choice.

After 12 weeks of treatment, the men in both groups had similar blood PSA levels, showing that both groups received enough of a dose to hit the drug’s target, explained Dr. Ratain.

Although levels of abiraterone in patients’ blood dipped lower between doses in men who took the lower dose with food than in men who took it on an empty stomach, this did not seem to influence responses to the drug. However, blood concentrations of abiraterone varied more widely between participants in men who took it on an empty stomach, the researchers found.

In both groups, men lived for an average of about 9 months without their disease progressing.

Larger studies are needed to measure whether the effects of abiraterone can be maintained in the long term when given at a reduced dose with food, wrote the study authors.

In an editorial that accompanied the trial results, Jill Kolesar, Pharm.D., of the University of Kentucky, and Glenn Liu, M.D., of the University of Wisconsin, cautioned doctors, patients, and insurance providers against making dosing decisions based on a small trial with limited follow-up.

The use of PSA testing to measure the effects of abiraterone could introduce extra uncertainty in a small trial, as results of PSA testing can normally vary between hospitals by as much as 20%, Drs. Kolesar and Liu wrote. In addition, they explained, the long-term repercussions of the lower levels of abiraterone in patients’ blood seen between doses in the food-effect group are not known.

But although the results of the trial are preliminary, Dr. Ratain thinks it could point to a reasonable strategy for patients who would otherwise not be able to take the drug at all because of cost, as long as they remain under careful supervision by their doctor.

Other Methods to Manipulate Drug Dose

The idea of harnessing the food effect is not new, said Dr. Ratain.

Previous studies have showed that giving pazopanib (Votrient), which is used to treat kidney cancer and sarcoma, with food doubles the amount of the drug that makes its way into the bloodstream. A trial of ibrutinib (Imbruvica) in patients with chronic lymphocytic leukemia showed that about one-third more of a dose of ibrutinib is processed by the body when it’s taken with food.

“The way [some] drugs are labeled and marketed today may not be optimal from a patient perspective,” Dr. Ratain commented.

The food effect is not the only method under study to decrease the required doses of some drugs. Other trials are testing medications that slow metabolism—the rate at which the body breaks down a drug—along with cancer drugs, noted Dr. Figg.

Other potential approaches that could be tested, Dr. Ratain said, include taking cancer drugs that naturally break down slowly in the body less often than directed by the label, or using shorter courses of some drugs.

Dr. Ratain and other US researchers recently founded a nonprofit organization, the Value in Cancer Care Consortium, to support more trials of cost-reduction strategies in oncology.

With newer drugs that hold the promise of ever-more-personalized treatment reaching the market, many patients are now prescribed drugs that cost more than $100,000 per year. Even with insurance, people will often face out-of-pocket costs of more than $10,000 annually for these treatments.

“We view the abiraterone study as proof of concept,” Dr. Ratain said, “and we’re now thinking about [trying these approaches] to reduce the cost of other drugs.”

Tagged with:

About author

Related Articles